Talent Risk · Employers · Pharma & healthcare
BioCryst Pharmaceuticals
- 47
- Jobs in announced cuts · 12 months
- 10.8%
- Of its staff · 12 months
- 4th Aug 2026
- Latest on record
BioCryst Pharmaceuticals is showing signs of job cuts.
Stepping down: cuts in the last 180 days, nothing new in 90. Latest, on 4th August: Biocryst Pharmaceuticals Inc filed a WARN notice for a closure affecting 47 employees at Hoover, AL, effective 2026-10-07.
This record counts only cuts announced publicly or filed as a formal notice; the everyday redundancies at any large employer are rarely announced and are not here.
How to read this page
- The label (Cutting, Signs or Quiet) comes from one published rule applied to the sources listed: the company, formal notices and named outlets. The rule
- The figures count each announcement once. Where a figure is left out, the record says why (one report only, offered not cut, same round).
- Summary says what is happening and what would change the label; Full record lists every report, linked.
What’s happening, and where
No announced or filed job cuts in the last 90 days. The label rests on earlier signs, under Full record.
Next This becomes Cutting if the company, a formal notice or two major outlets confirm cuts.
The last 12 months
No cuts found this quarter. We found cuts in 1 of the three quarters before.
This label is our opinion, reached by applying one published rule to the sources listed. BioCryst Pharmaceuticals can correct the record at any time.
At a glance
| Label | Signs since the week to 7th Nov |
|---|---|
| Jobs in announced cuts, 12 months | 47 · 10.8% of about 435 staff |
| Latest on the record | 4th August 2026 · Cuts announced · 47 jobs |
| Where the jobs are | Alabama · Hoover, AL · US |
| Jobs we count | All 47 jobs reported. How we count |
| Normal for them? | No cuts found this quarter. We found cuts in 1 of the three quarters before. |
| Sources, 12 months | 1 formal notice, each linked below |
| Headquarters · sector | US · Pharma & healthcare · BCRX |
Identifiers Wikidata Q4914611 · LEI 549300Z0INP1Z5NP6J59 · SEC CIK 0000882796 · ISIN US09058V1035 · BCRX on Nasdaq · About these
What happened
Every event on the record, newest first. Each has its own page; open a row’s reports to see every source. How we decide
Nothing from BioCryst Pharmaceuticals, a formal notice or a named outlet about its workforce in the last 90 days.
Earlier on the record (1 event, up to a year)
- 4th AugBioCryst Pharmaceuticals files a WARN notice for 47 jobs in Alabama47jobs cut
Biocryst Pharmaceuticals Inc filed a WARN notice for a closure affecting 47 employees at Hoover, AL, effective 2026-10-07.
The source: WARN notice (AL)
- 4th Aug
WARN notice (AL) Official
Biocryst Pharmaceuticals Inc filed a WARN notice for a closure affecting 47 employees at Hoover, AL, effective 2026-10-07.
- 4th Aug
Background and commentary (1): in the news, never counted
- 4th NovBioCryst Pharmaceuticals: otherNo figure
BioCryst Pharmaceuticals reported restructuring costs totalling $15.6 million in Q3 2026, including $6.3 million cash costs and $9.3 million non-cash costs associated with closure of Birmingham site and employee termination costs.
The source: SEC EDGAR
- 4th Nov
SEC EDGAR Official
BioCryst Pharmaceuticals reported restructuring costs totalling $15.6 million in Q3 2026, including $6.3 million cash costs and $9.3 million non-cash costs associated with closure of Birmingham site and employee termination costs.
- 4th Nov
In context
How the label has changed · 26 weeks
| 7th Nov | Cutting → Signs · Stepping down: cuts in the last 180 days, nothing new in 90 |
|---|---|
| 8th Aug | Quiet → Cutting · Confirmed by the company or a formal notice (such as a US WARN notice) |
Against its workforce
Share of its sector’s cuts
2%
of the 2,796 job cuts announced in 12 months by the employers we rate in pharma & healthcare.
Peers in pharma & healthcare
- BioCryst Pharmaceuticals10.8%
- GSK1.8%
- AstraZeneca0.7%
- Novartis0.4%
- Novo Nordisk0.4%
- Johnson & Johnson0.2%
Job cuts in 12 months as a share of each employer’s workforce.
Right of reply
BioCryst Pharmaceuticals can reply or correct this record at any time.
This label is our opinion, reached by applying one published rule to the sources listed.